|
|
|
|
|
Last Trade
|
Last Trade:
$0.04
|
Change:
0.00 (0.00%)
|
Trade Time:
Feb 08
|
Market Cap:
$0.66M
|
|
|
|
|
Description of Business
|
|
Immtech Pharmaceuticals, Inc. (the "Registrant") is focused on
developing and commercializing drugs for infectious diseases. We target diseases
with significant unmet medical needs and well-defined endpoints that can be
evaluated in clinical trials of relatively short duration. Our strategy is to
develop and commercialize a pipeline of new drugs to treat infectious diseases
and other disorders. Infectious diseases in the global population have increased
significantly during the past 20 years and, according to the World Health
Organization ("WHO"), are the most common cause of death worldwide. Relatively
few new drugs for the treatment of infectious diseases have been brought to
market during the past two decades.
|
|
|
|